| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
153,922,000 |
| Market
Cap: |
6.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$36.9 - $39.95 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
40,000 |
561,286 |
| Total Sell Value |
$0 |
$0 |
$1,546,400 |
$15,378,126 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
30 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guyer David R |
Chief Executive Officer |
• • – |
2016-07-01 |
4 |
OE |
$10.03 |
$241,322 |
D/D |
24,060 |
56,451 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-06-30 |
4 |
AS |
$50.94 |
$1,115,319 |
D/D |
(21,846) |
191,531 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-06-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
213,377 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-06-29 |
4 |
AS |
$51.37 |
$1,028,321 |
D/D |
(20,000) |
173,377 |
|
- |
|
| Bolte Axel |
Director |
– • – |
2016-06-03 |
4 |
B |
$56.97 |
$199,395 |
D/D |
3,500 |
6,000 |
2.39 |
- |
|
| Sblendorio Glenn |
EVP, COO & CFO, Treasurer |
• – – |
2016-06-02 |
4 |
S |
$57.20 |
$38,381 |
D/D |
(671) |
1,079 |
|
- |
|
| Ross Michael Jay |
Director |
– • – |
2016-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-06-01 |
4 |
AS |
$52.59 |
$1,584,505 |
D/D |
(30,060) |
32,391 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-06-01 |
4 |
OE |
$10.03 |
$301,502 |
D/D |
30,060 |
62,451 |
|
- |
|
| Sblendorio Glenn |
EVP, COO & CFO, Treasurer |
• – – |
2016-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-05-31 |
4 |
AS |
$52.03 |
$1,066,431 |
D/D |
(20,000) |
193,377 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-05-31 |
4 |
OE |
$13.22 |
$15,661 |
D/D |
1,185 |
213,377 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2016-05-24 |
4 |
S |
$49.00 |
$63,700,000 |
D/D |
(1,300,000) |
3,610,489 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-05-02 |
4 |
AS |
$46.01 |
$1,018,738 |
D/D |
(22,060) |
32,391 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-05-02 |
4 |
OE |
$10.03 |
$221,262 |
D/D |
22,060 |
54,451 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-04-29 |
4 |
AS |
$46.71 |
$935,875 |
D/D |
(20,000) |
212,192 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-04-29 |
4 |
OE |
$1.65 |
$17,982 |
D/D |
2,597 |
232,192 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
AS |
$41.98 |
$972,984 |
D/D |
(22,060) |
32,391 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
OE |
$10.03 |
$221,262 |
D/D |
22,060 |
54,451 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-03-29 |
4 |
AS |
$40.83 |
$836,909 |
D/D |
(20,000) |
229,595 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-03-29 |
4 |
OE |
$1.65 |
$17,994 |
D/D |
2,597 |
249,595 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-03-01 |
4 |
AS |
$44.61 |
$1,003,310 |
D/D |
(22,060) |
32,391 |
|
- |
|
| Guyer David R |
Chief Executive Officer |
• • – |
2016-03-01 |
4 |
OE |
$10.03 |
$221,262 |
D/D |
22,060 |
54,451 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-02-29 |
4 |
AS |
$45.04 |
$902,503 |
D/D |
(20,000) |
246,998 |
|
- |
|
| Patel Samir Chandrakant |
President |
• • – |
2016-02-29 |
4 |
OE |
$1.65 |
$47,777 |
D/D |
6,087 |
266,998 |
|
- |
|
468 Records found
|
|
Page 12 of 19 |
|
|
